AZRX - AzurRx BioPharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 521.74M
Enterprise Value 323.88M
Trailing P/E N/A
Forward P/E 1-1.43
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.05
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.78

Trading Information

Stock Price History

Beta (3Y Monthly) 2.25
52-Week Change 3-59.14%
S&P500 52-Week Change 36.34%
52 Week High 33.7500
52 Week Low 30.9050
50-Day Moving Average 31.5808
200-Day Moving Average 32.0889

Share Statistics

Avg Vol (3 month) 3184.4k
Avg Vol (10 day) 3735.3k
Shares Outstanding 512.6M
Float 16.23M
% Held by Insiders 132.82%
% Held by Institutions 114.89%
Shares Short (Jun 28, 2019) 4266.32k
Short Ratio (Jun 28, 2019) 42.74
Short % of Float (Jun 28, 2019) 41.58%
Short % of Shares Outstanding (Jun 28, 2019) 41.26%
Shares Short (prior month May 31, 2019) 4260.07k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-125.23%
Return on Equity (ttm)-764.01%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.44M
Net Income Avi to Common (ttm)-14.56M
Diluted EPS (ttm)-0.8690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)413.86k
Total Cash Per Share (mrq)0.02
Total Debt (mrq)2.18M
Total Debt/Equity (mrq)80.22
Current Ratio (mrq)0.49
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)-11.28M
Levered Free Cash Flow (ttm)-4.89M